Department of Orthopedic Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
PLoS One. 2021 Mar 3;16(3):e0247845. doi: 10.1371/journal.pone.0247845. eCollection 2021.
Increased blood loss remains a major drawback of simultaneous bilateral total hip arthroplasty (SBTHA). We examined the effects of disusing closed suction drainage (CSD) on postoperative blood loss and transfusion requirement in cementless SBTHA.
A retrospective cohort study was conducted with a consecutive series of cementless SBTHAs performed by a single surgeon between January 2014 and March 2017. The surgeon routinely used CSD until May 2015 and refrained from CSD in all primary THAs thereafter. This study included SBTHAs with intravenous administration of tranexamic acid (TXA). Postoperative hemoglobin drop, blood loss, transfusion rate, pain scores, complication rates, and implant survivorships were compared between the groups of SBTHA with and without CSD. The minimum follow-up duration was 1 year.
Among the 110 patients (220 hips), 46 (92 hips) and 64 (128 hips) underwent SBTHA with and without CSD, respectively. Maximum hemoglobin drop (mean, 4.8 vs. 3.9 g/dL; P = 0.001), calculated blood loss (mean, 1530 vs. 1190 mL; P<0.001), transfusion rate (45.7% vs. 21.9%; P = 0.008), and length of hospital stay (mean, 6.6 vs. 5.8 days; P = 0.004) were significantly lower in patients without CSD. There were no significant differences in postoperative pain scales and wound complication rates. The mean Harris Hip scores at final follow-up (92.5 vs. 92.1; P = 0.775) and implant survivorships with an end-point of any revision at 4 years (98.9% vs. 98.4%; log-rank, P = 0.766) were similar between groups.
Disusing CSD significantly reduced postoperative blood loss and transfusion requirement without increasing postoperative pain and surgical wound complications in cementless SBTHA with concurrent administration of intravenous TXA.
失血增加仍然是同期双侧全髋关节置换术(SBTHA)的主要缺点。我们研究了在非骨水泥 SBTHA 中停用闭式引流(CSD)对术后失血和输血需求的影响。
对 2014 年 1 月至 2017 年 3 月间由同一位外科医生连续进行的非骨水泥 SBTHA 进行了回顾性队列研究。外科医生常规使用 CSD 直至 2015 年 5 月,此后所有初次髋关节置换术均不使用 CSD。本研究包括静脉注射氨甲环酸(TXA)的 SBTHA。比较了 SBTHA 有和无 CSD 组之间术后血红蛋白下降、失血量、输血率、疼痛评分、并发症发生率和植入物存活率。最低随访时间为 1 年。
在 110 例患者(220 髋)中,46 例(92 髋)和 64 例(128 髋)分别行 SBTHA 有和无 CSD。无 CSD 组最大血红蛋白下降(平均 4.8 比 3.9 g/dL;P=0.001)、计算失血量(平均 1530 比 1190 mL;P<0.001)、输血率(45.7%比 21.9%;P=0.008)和住院时间(平均 6.6 比 5.8 天;P=0.004)均显著降低。术后疼痛评分和伤口并发症发生率无显著差异。末次随访时平均 Harris 髋关节评分(92.5 比 92.1;P=0.775)和 4 年时任何翻修终点的植入物存活率(98.9%比 98.4%;log-rank,P=0.766)在两组间相似。
在非骨水泥 SBTHA 中联合应用静脉 TXA 时,停用 CSD 可显著减少术后失血和输血需求,而不增加术后疼痛和手术伤口并发症。